NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/26/2022
Back to search
Official data from USPTO
RPHARMY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
07/26/2022
Trademark type
Combined
Nice classes
42
Filing date
05/11/2021
Registration date
07/26/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/26/2022
Last transaction
07/26/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/15/2019
First use in commerce
05/15/2019
Drawing code
3
Owner type
16
Owner location
AUSTIN, TX
Examiner
VAUSS, JERAMEY
Law office
T20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "RPHARMPY" in distinctive stylized font. To the left of the mark is a small flag with a cross at the center.
Holders and representatives
Holders
RPHARMY, LLC
Representatives
John C. Cain Munck Wilson Mandala, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing temporary use of non-downloadable software solutions for medical formulary management and providing hazardous drug safety information
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/26/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/10/2022
PUBO
PUBLISHED FOR OPPOSITION
05/10/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/20/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/17/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/17/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/17/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/17/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/24/2022
GNRT
NON-FINAL ACTION E-MAILED
01/24/2022
CNRT
NON-FINAL ACTION WRITTEN
01/24/2022
DOCK
ASSIGNED TO EXAMINER
01/18/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/12/2021
NWAP
NEW APPLICATION ENTERED
05/14/2021
Continuous trademark protection
Get notified about every new filing that threatens RPHARMY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.